Biology and pathogenesis of Fonsecaea pedrosoi, the major etiologic agent of chromoblastomycosis

FEMS Microbiology Reviews

Volumn 31, Issue 5, 2007, Pages 570-591

  Santos, André L S ^a   Palmeira, Vanila F ^a   Rozental, Sonia ^a   Kneipp, Lucimar F ^b   Nimrichter, Leonardo ^a   Alviano, Daniela S ^a   Rodrigues, Marcio L ^a   Alviano, Celuta S ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Cellular interaction; Chromoblastomycosis; Differentiation; Fonsecaea pedrosoi; Pathogenic mechanisms

Indexed keywords

ADHESIN; AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; FLUCYTOSINE; GLYCOSYLCERAMIDE; ITRACONAZOLE; KETOCONAZOLE; MELANIN; MEMBRANE LIPID; MONOCLONAL ANTIBODY; PROPRANOLOL; SIALIC ACID; TERBINAFINE; UNCLASSIFIED DRUG;

BIOLOGICAL ACTIVITY; CELL DIFFERENTIATION; CELL INTERACTION; CHROMOMYCOSIS; FONSECAEA PEDROSOI; IMMUNE RESPONSE; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; REVIEW; TREATMENT DURATION;

ASCOMYCOTA; CHROMOBLASTOMYCOSIS; HUMANS;

FONSECAEA PEDROSOI; FUNGI;

EID: 34547830893     PISSN: 01686445     EISSN: 15746976     Source Type: Journal    
DOI: 10.1111/j.1574-6976.2007.00077.x     Document Type: Review

References (192)

1. Abliz P, Fukushima K, Takizawa K, Nieda N, Miyaji M Nishimura K (2003) Rapid identification of the genus Fonsecaea by PCR with specific oligonucleotide primers. J Clin Microbiol 41 : 873 876.
2. Abliz P, Fukushima K, Takizawa K Nishimura K (2004) Identification of pathogenic dematiaceous fungi and related taxa based on large subunit ribosomal DNA D1/D2 domain sequence analysis. FEMS Immunol Med Microbiol 40 : 41 49.
3. Ahrens J, Graybill JR, Abishawl A, Tio FO Rinaldi MG (1989) Experimental murine chromomycosis mimicking chronic progressive human disease. Am J Trop Med Hyg 40 : 651 658.
4. Al-Hedaithy SS, Jamjoom ZA Saeed ES (1988) Cerebral phaeohyphomycosis caused by Fonsecaea pedrosoi in Saudi Arabia. APMIS 3 : 94 100.
5. Alviano CS, Farbiarz SR, De Souza W, Angluster J Travassos LR (1991) Characterization of Fonsecaea pedrosoi melanin. J Gen Microbiol 137 : 837 844.
6. Alviano CS, Travassos LR, Angluster J De Souza W (1992) Effect of environmental factors on Fonsecaea pedrosoi morphogenesis with emphasis on sclerotic cells induced by propranolol. Mycopathologia 119 : 17 23.
7. Alviano CS, Travassos LR Schauer R (1999) Sialic acids in fungi: a minireview. Glycoconj J 16 : 545 554.
8. Alviano DS, Kneipp LF, Lopes AHCS, Travassos LR, Meyer-Fernandes JR, Rodrigues ML Alviano CS (2003) Differentiation of Fonsecaea pedrosoi mycelial forms into sclerotic cells is induced by platelet-activating factor. Res Microbiol 154 : 689 695.
9. Alviano DS, Franzen AJ, Travassos LR, Holandino C, Rozental S, Ejzemberg R, Alviano CS Rodrigues ML (2004a) Melanin from Fonsecaea pedrosoi induces production of human antifungal antibodies and enhances the antimicrobial efficacy of phagocytes. Infect Immun 72 : 229 237.
10. Alviano DS, Rodrigues ML, Almeida CA, Santos ALS, Couceiro JNSS, Soares RMA, Travassos LR Alviano CS (2004b) Differential expression of sialylglycoconjugates and sialidase activity in distinct morphological stages of Fonsecaea pedrosoi. Arch Microbiol 181 : 278 286.
11. Andrade TS, Castro LG, Nunes RS, Gimenes VM Cury AE (2004) Susceptibility of sequential Fonsecaea pedrosoi isolates from chromoblastomycosis patients to antifungal agents. Mycoses 47 : 216 221.
12. Barreto-Bergter E, Pinto MR Rodrigues ML (2004) Structure and biological functions of fungal cerebrosides. An Acad Bras Cienc 76 : 67 84.
13. Bittencourt AL, Londero AT Andrade JAF (1994) Cromoblastomiose auricular. Relato de um caso. Rev Inst Med Trop São Paulo 36 : 381 383.
14. Blinova MI, Yudintseva NM, Kalmykova NV, Kuzminykh EV, Yurlova NA, Ovchinnikova OA Potokin IL (2003) Effect of melanins from black yeast fungi on proliferation and differentiation of cultivated human keratinocytes and fibroblasts. Cell Biol Int 27 : 135 146.
15. Bocca AL, Brito PP, Figueiredo F Tosta CE (2006) Inhibition of nitric oxide production by macrophages in chromoblastomycosis: a role for Fonsecaea pedrosoi melanin. Mycopathologia 161 : 195 203.
16. Bonifaz A, Martinez-Soto E, Carrasco-Gerard E Peniche J (1997) Treatment of chromoblastomycosis with itraconazole, cryosurgery and combination of both. Int J Dermatol 36 : 542 547.
17. Bonifaz A, Carrasco-Gerard E Saul A (2001) Chromoblastomycosis: clinical and mycologic experience of 51 cases. Mycoses 44 : 1 7.
18. Bonifaz A, Paredes-Solis V Saul A (2004) Treating chromoblastomycosis with systemic antifungals. Expert Opin Pharmacother 5 : 247 254.
19. Brandt ME Warnock DW (2003) Epidemiology, clinical manifestations, and therapy of infection caused by dematiaceous fungi. J Chemother 15 : 36 47.
20. Breitwieser GE (2006) Calcium sensing receptors and calcium oscillations: calcium as a first messenger. Curr Top Dev Biol 73 : 85 114.
21. Brown DL (1993) The interpretation of tests of T-cell and natural killer cell function in man. Clinical Aspects of Immunology (Lachmann PJ, Peters SDK, Rosen FS Walport MJ, eds), pp. 843 858. Blackwell Sci. Publication, Boston.
22. Caligiorne RB, De Resende MA, Dias-Neto E, Oliveira SC Azevedo V (1999) Dematiaceous fungal pathogens: analysis of ribosomal DNA gene polymorphism by polymerase chain reaction-restriction fragment length polymorphism. Mycoses 42 : 609 614.
23. Caligiorne RB, Licinio P, Dupont J De Hoog GS (2005) Internal transcribed spacer rRNA gene-based phylogenetic reconstruction using algorithms with local and global sequence alignment for black yeasts and their relatives. J Clin Microbiol 43 : 2816 2823.
24. Caplan RM (1968) Epidermoid carcinoma arising in extensive chromoblastomycosis. Arch Dermatol 97 : 38 41.
25. Casolari C, Rossib T, Baggioc G, Coppic A, Zandomeneghic G, Rubertoc AI, Farinad C, Fabioa G, Zancae A Castellic M (2004) Interaction between saquinavir and antimycotic drugs on C. albicans and C. neoformans strains. Pharmacol Res 50 : 605 610.
26. Cassone A, De Bernardis F, Torosantucci A, Tacconelli E, Tumbarello M Cauda R (1999) In vitro and in vivo anticandidal activity of human immunodeficiency virus protease inhibitors. J Infect Dis 180 : 448 453.
27. Castro LG, Pimentel ER Lacaz CS (2003) Treatment of chromomycosis by cryosurgery with liquid nitrogen: 15 years' experience. Int J Dermatol 42 : 408 412.
28. Chao W Olson MS (1993) Platelet-activating factor: receptors and signal transduction. Biochem J 292 : 617 629.
29. Chaskes S Tyndall RL (1978) Pigment production by Cryptococcus neoformans and other Cryptococcus species from aminophenols and diaminobenzenes. J Clin Microbiol 7 : 146 152.
30. Collopy-Junior I, Rodrigues ML, Alviano CS, Travassos LR Meyer-Fernandes JR (2005) Characterization of an ecto-ATPase activity in Cryptococcus neoformans. FEMS Yeast Res 5 : 899 907.
31. Collopy-Junior I, Kneipp LF, Da Silva FC, Rodrigues ML, Alviano CS Meyer-Fernandes JR (2006) Characterization of an ecto-ATPase activity in Fonsecaea pedrosoi. Arch Microbiol 185 : 355 362.
32. Coombs GH, Goldberg DE, Klemba M, Berry C, Kay J Mottram JC (2001) Aspartic proteases of Plasmodium falciparum and other parasitic protozoa as drug targets. Trends Parasitol 17 : 532 537.
33. Cooper BH (1985) Phialophora verrucosa and other chromoblastomycotic fungi. Fungal Dimorphism with Emphasis on Fungi Pathogenic for Humans (Szaniszlo PJ, ed), pp. 263 280. Plenum Press, New York.
34. Corbellini VA, Scroferneker ML, Carissimi M Santolin LD (2006) Delayed-type hypersensitivity response to crude and fractionated antigens from Fonsecaea pedrosoi CMMI 1 grown in different culture media. Mycopathologia 162 : 51 55.
35. Cunha MM, Franzen AJ, Alviano DS, Zanardi E, Alviano CS, De Souza W Rozental S (2005) Inhibition of melanin synthesis pathway by tricyclazole increases susceptibility of Fonsecaea pedrosoi against mouse macrophages. Microsc Res Tech 68 : 377 384.
36. D'Acquisto F, Carnuccio R, d'Ischia M Misuraca G (1995) 5,6-Dihydroxyindole-2-carboxylic acid, a diffusible melanin precursor, is a potent stimulator of lipopolysaccharide-induced production of nitric oxide by J774 macrophages. Life Sci 57 : PL401 PL406.
37. D'Avila SC, Pagliari C Duarte MI (2003) The cell-mediated immune reactions in the cutaneous lesion of chromoblastomycosis and their correlaction with different clinical forms of the disease. Mycopathologia 156 : 51 60.
38. Dash C, Kulkarni A, Dunn B Rao M (2003) Aspartic peptidase inhibitors: implications in drug development. Crit Rev Biochem Mol Biol 38 : 89 119.
39. Da Silva AF, Rodrigues ML, Farias SE, Almeida IC, Pinto MR Barreto-Bergter E (2004) Glucosylceramides in Colletotrichum gloeosporioides are involved in the differentiation of conidia into mycelial cells. FEBS Lett 561 : 137 143.
40. De Bedout C, Gomez BL Restrepo A (1997) In vitro susceptibility testing of Fonsecaea pedrosoi to antifungals. Rev Inst Med Trop São Paulo 39 : 145 148.
41. De Hoog GS, Queiroz-Telles F, Haase G et al 2000) Black fungi: clinical and pathogenic approaches. Med Mycol 38 : 243 250.
42. De Hoog GS, Attili-Angelis D, Vicente VA, Van Den Ende AH Queiroz-Telles F (2004) Molecular ecology and pathogenic potential of Fonsecaea species. Med Mycol 42 : 405 416.
43. Del Poeta M, Schell WA Perfect JR (1997) In vitro antifungal activity of pneumocandin L-743,872 against a variety of clinically important molds. Antimicrob Agents Chemother 41 : 1835 1836.
44. Dennehy KM Brown GD (2007) The role of the {beta}-glucan receptor Dectin-1 in control of fungal infection. J Leukoc Biol. Epub ahead of print, DOI :.
45. Develoux M, Dieng MT, Ndiaye B, Raphenon G Lepers JP (2006) Chromomycosis caused by Exophilia spinifera in Sahelian Africa. Ann Dermatol Venereol 133 : 68 69.
46. Dixon DM Polak-Wyss A (1991) The medically important dematiaceous fungi and their identification. Mycoses 34 : 1 18.
47. Dos Santos Gon A Minelli L (2006) Melanoma in a long-standing lesion of chromoblastomycosis. Int J Dermatol 45 : 1331 1333.
48. Elgart GW (1996) Chromoblastomycosis. Dermatol Clin 14 : 77 83.
49. El-Obeid A, Hassib A, Ponten F Westermark B (2006) Effect of herbal melanin on IL-8: a possible role of Toll-like receptor 4 (TLR4). Biochem Biophys Res Commun 344 : 1200 1206.
50. Espinel-Ingroff A (1997) Clinical relevance of antifungal resistance. Inf Dis Clin N Am 11 : 929 944.
51. Esterre P Queiroz-Telles F (2006) Management of chromoblastomycosis: novel perspectives. Curr Opin Infect Dis 19 : 148 152.
52. Esterre P, Ravisse P Peyrol S (1991) Immunopathologie de la lésion cutanée de chromomycose. J Mycol Méd 1 : 201.
53. Esterre P, Peyrol S, Sainte-Marie D, Pradinaud R Grimaud JA (1993) Granulomatous reaction and tissue remodeling in the cutaneous lesion of chromoblastomycosis. Virchows Arch Pathol Anat 422 : 285 291.
54. Esterre P, Andriantsimhavandy A, Ramarcel ER Pecarrere JL (1996) Forty years of chromoblastomycosis in Madagascar: a review. Am J Trop Med Hyg 55 : 45 47.
55. Esterre P, Jahevitra M, Ramarcel E Andriantsimahavandy A (1997) Evaluation of the ELISA technique for the diagnosis and the seroepidemiology of chromoblastomycosis. J Mycol Med 7 : 137 141.
56. Esterre P, Jahevitra M Andriantsimahavandy A (2000) Humoral immune response in chromoblastomycosis during and after therapy. Clin Diagn Lab Immunol 7 : 497 500.
57. Farbiarz SR, De Carvalho TU, Alviano C De Souza W (1990) Fine structure and cytochemistry of the interaction between Fonsecaea pedrosoi and mouse resident macrophages. J Med Vet Mycol 28 : 373 383.
58. Farbiarz SR, De Carvalho TU, Alviano CS De Souza W (1992) Inhibitory effect of melanin on the interaction of Fonsecaea pedrosoi with mammalian cells in vitro. J Med Vet Mycol 30 : 265 273.
59. Fondati A, Gallo MG, Romano E Fondevila D (2001) A case of feline phaeohyphomycosis due to Fonsecaea pedrosoi. Vet Dermatol 12 : 297 301.
60. Foster HM Harris TJ (1987) Malignant change (squamous carcinoma) in chronic chromoblastomycosis. Aust N Z J Surg 57 : 775 777.
61. Franzen AJ, De Souza W, Farina M, Alviano CS Rozental S (1999) Morphometric and densitometric study of the biogenesis of electron-dense granules in Fonsecaea pedrosoi. FEMS Microbiol Lett 173 : 395 402.
62. Franzen AJ, Cunha MM, Batista EJ, Seabra SH, De Souza W Rozental S (2006) Effects of tricyclazole (5-methyl-1,2,4-triazol[3,4] benzothiazole), a specific DHN-melanin inhibitor, on the morphology of Fonsecaea pedrosoi conidia and sclerotic cells. Microsc Res Tech 69 : 729 37.
63. Fuchs J Pecher S (1992) Partial suppression of cell mediated immunity in chromoblastomycosis. Mycopathologia 119 : 73 76.
64. Fukushiro R (1983) Chromoblastomycosis in Japan. Int J Dermatol 22 : 221 229.
65. Gimenes VMF, De Souza MG, Ferreira KS, Marques SG, Gonçalves AG, Santos DVCL, Silva CMP Almeida SR (2005) Cytokines and lymphocyte proliferation in patients with different clinical forms of chromoblastomycosis. Microbes Infect 7 : 708 713.
66. Gomez BL Nosanchuk JD (2003) Melanin and fungi. Curr Opin Infect Dis 16 : 91 96.
67. Gomez BL, Nosanchuk JD Diez S (2001) Detection of melanin-like pigments in the dimorphic fungal pathogen Paracoccidioides brasiliensis in vitro and during infection. Infect Immun 69 : 5760 5767.
68. Gupta AK, Taborda PR Sanzovo AD (2002) Alternate week and combination itraconazole and terbinafine therapy for chromoblastomycosis caused by Fonsecaea pedrosoi in Brazil. Med Mycol 40 : 529 534.
69. Hakomori S (2003) Structure, organization, and function of glycosphingolipids in membrane. Curr Opin Hematol 10 : 16 24.
70. Hamza SH, Mercado PJ, Skelton HG Smith KJ (2003) An unusual dematiaceous fungal infection of the skin caused by Fonsecaea pedrosoi: a case report and review of the literature. J Cutan Pathol 30 : 340 343.
71. Hayakawa M, Ghosn EEB, de Sousa MGT, Ferreira KS Almeida SR (2006) Phagocytosis, production of nitric oxide and pro-inflammatory cytokines by macrophages in the presence of dematiaceus fungi that causes chromoblastomycosis. Scand J Immunol 64 : 382 387.
72. Hernandez-Hernandez F, De Bievre C, Camacho-Arroyo I, Cerbon MA, Dupont B Lopez-Martinez R (1995) Sex hormone effects on Phialophora verrucosa in vitro and characterization of progesterone receptors. J Med Vet Mycol 33 : 235 239.
73. Hira K, Yamada H, Takahashi YR Ogawa H (2002) Successful treatment of chromoblastomycosis using carbon dioxide laser associated with topical heat applications. J Eur Acad Dermatol Venereol 16 : 273 275.
74. Hirsch BC Johnson WC (1984) Pathology of granulomatous diseases: mixed inflammatory granulomas. Int J Dermatol 23 : 585 597.
75. Hube B (2000) Extracellular peptidases of human pathogenic fungi. Contrib Microbiol 5 : 126 137.
76. Hube B Naglik J (2001) Candida albicans proteinases: resolving the mystery of a gene family. Microbiology 147 : 1997 2005.
77. Höfling-Lima AL, Guarro J, Freitas D, Godoy P, Gene J, Souza LB, Zaror L Romano AC (2005) Clinical treatment of corneal infection due to Fonsecaea pedrosoi-case report. Arq Bras Oftalmol 68 : 270 272.
78. Hunter T (1995) Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling. Cell 80 : 225 236.
79. Ibrahim-Granet O, Danguet C, Dennetiere B Bievre C (1987) Etude en microscopie électronique à transmission des cellules fumagoides de Cladosporium carrionii obtenues à pH 2.5 et de Fonsecaea pedrosoi obtenues sur milieu de Francis. Comparision aux cellules observées dans les lésions humaines. Bull Soc Fr Mycol Med 16 : 257 262.
80. Jost BH, Songer JG Billington SJ (2001) Cloning, expression, and characterization of a neuraminidase gene from Arcanobacterium pyogenes. Infect Immun 69 : 4430 4437.
81. Kennedy AD, Willment JA, Dorward DW, Williams DL, Brown GD DeLeo FR (2007) Dectin-1 promotes fungicidal activity of human neutrophils. Eur J Immunol 37 : 467 478.
82. Kneipp LF, Palmeira VF, Pinheiro AAS, Alviano CS, Rozental S, Travassos LR Meyer-Fernandes JR (2003) Phosphatase activity on the cell wall of Fonsecaea pedrosoi. Med Mycol 41 : 469 477.
83. Kneipp LF, Rodrigues ML, Holandino C, Esteves FF, Souto-Padrón T, Alviano CS, Travassos LR Meyer-Fernandes JR (2004) Ecto-phosphatase activity in conidial forms of Fonsecaea pedrosoi is modulated by exogenous phosphate and influences fungal adhesion to mammalian cells. Microbiology 150 : 3355 3362.
84. Kohl NE, Emini EA, Schleif WA, Davis LJ, Heimbach JC, Dixon RA, Scolnick EM Sigal IS (1988) Active human immunodeficiency virus protease is required for viral infectivity. Proc Natl Acad Sci USA 85 : 4686 4690.
85. Kondo M, Hiruma M, Nishioka Y, Mayuzumi N, Mochida K, Ikeda S Ogawa H (2005) A case of chromomycosis caused by Fonsecaea pedrosoi and a review of reported cases of dematiaceous fungal infection in Japan. Mycoses 48 : 221 225.
86. Kwon-Chung KJ Bennett JE (1992) Chromoblastomycosis. Medical Mycology (Cann C Hunsberger S, eds), pp. 337 355. Lea and Febiger Inc., Philadelphia.
87. Levery SB, Momany M, Lindsey R, Toledo MS, Shayman JA, Fuller M, Brooks K, Doong RL, Straus AH Takahashi HK (2002) Disruption of the glucosylceramide biosynthetic pathway in Aspergillus nidulans and Aspergillus fumigatus by inhibitors of UDP-Glc: ceramide glucosyltransferase strongly affects spore germination, cell cycle, and hyphal growth. FEBS Lett 525 : 59 64.
88. Levitz SM (2004) Interactions of Toll-like receptors with fungi. Microbes Infect 6 : 1351 1355.
89. Limongi CL, Rozental S, Alviano CS De Souza W (1997) The influence of surface carbohydrates on the interaction of Fonsecaea pedrosoi with Chinese hamster ovary glycosylation mutant cells. Mycophatologia 138 : 127 135.
90. Limongi CL, Alviano CS, De Souza W Rozental S (2001) Isolation and partial characterization of an adhesion from Fonsecaea pedrosoi. Med Mycol 39 : 429 437.
91. Limongi CL, De Souza W Rozental S (2003) Protein kinase antagonists inhibit invasion of mammalian cells by Fonsecaea pedrosoi. J Med Microbiol 52 : 201 209.
92. Lopes AHCS, Dutra PML, Rodrigues CO, Soares MJ, Angluster J Cordeiro RSB (1997) Effect of platelet-activating factor on the process of cellular differentiation of Herpetomonas muscarum muscarum. J Eukaryot Microbiol 44 : 321 325.
93. Lopez Martinez R Mendez Tovar LJ (2007) Chromoblastomycosis. Clin Dermatol 25 : 188 194.
94. Lupi O, Tyring SK McGinnis MR (2005) Tropical dermatology: fungal tropical diseases. J Am Acad Dermatol 53 : 931 951.
95. Lynch DV, Caffrey M, Hogan JL Steponkus PL (1992) Calorimetric and x-ray diffraction studies of rye glucocerebroside mesomorphism. Biophys J 61 : 1289 1300.
96. Marks MS Seabra MC (2001) The melanosome: membrane dynamics in black and white. Nat Rev Mol Cell Biol 2 : 738 748.
97. Marques SG, Silva CM, Saldanha PC, Rezende MA, Vicente VA, Queiroz-Telles F Costa JM (2006) Fonsecaea pedrosoi from the shell of the babassu coconut (Orbignya phalerata Martius) in the Amazon region of Maranhão Brazil. Nippon Ishinkin Gakkai Zasshi 47 : 305 311.
98. Matsumoto T Ajello L (1991) Dematiaceous fungi potentially pathogenic for humans and lower animals. Handbook of Applied Mycology (Arora DK, Ajello L Mukerji KG, eds), pp. 117 161. Marcel Decker Inc., New York.
99. McGinnis M (1983) Chromoblastomycosis and phaeohyphomycosis: new concepts, diagnosis and mycology. J Am Acad Dermatol 8 : 1 16.
100. Mednick AJ, Nosanchuk JD Casadevall A (2005) Melanization of Cryptococcus neoformans affects lung inflammatory responses during cryptococcal infection. Infect Immun 73 : 2012 2019.
101. Mendes-Giannini MJS, Soares CP, Monteiro da Silva JL Andreotti PF (2005) Interaction of pathogenic fungi with host-cells: molecular and cellular approaches. FEMS Immunol Med Microbiol 45 : 383 394.
102. Mendoza L, Karuppayil SM Szaniszlo PJ (1993) Calcium regulates in vitro dimorphism in chromoblastomycotic fungi. Mycoses 36 : 157 164.
103. Meyer-Fernandes JR (2002) Ecto-ATPases in protozoa parasites: looking for a function. Parasitol Int 51 : 299 303.
104. Meyer-Fernandes JR, Dutra PML, Rodrigues CO, Saad-Nehme J Lopes AHCS (1997) Mg2+-dependent ecto-ATPase activity in Leishmania tropica. Arch Biochem Biophys 341 : 40 46.
105. Minotto R, Bernardi CD, Mallmann LF, Edelweiss MI Scroferneker ML (2001) Chromoblatomycosis: a review of 100 cases in the state of Rio Grande do Sul, Brazil. J Am Dermatol 44 : 585 592.
106. Monod M, Jaton-Ogay K Reichard U (1999) Aspergillus fumigatus-secreted proteases as antigenic molecules and virulence factors. Contrib Microbiol 2 : 182 192.
107. Monod M, Capoccia S, Lechenne B, Zaugg C, Holdom M Jousson O (2002) Secreted proteases from pathogenic fungi. Int J Med Microbiol 292 : 405 419.
108. Morris-Jones R, Youngchim S Gomez BL (2003) Synthesis of melanin-like pigments by Sporothrix schenckii in vitro and during mammalian infection. Infect Immun 71 : 4026 4033.
109. Morris-Jones R, Gomez BL Diez S (2005) Synthesis of melanin pigment by Candida albicans in vitro and during infection. Infect Immun 73 : 6147 6150.
110. Naglik JR, Challacombe SJ Hube B (2003) Candida albicans secreted aspartyl peptidases in virulence and pathogenesis. Microbiol Mol Biol Rev 67 : 400 428.
111. Nathan CF, Silverstein SC, Brukner LH Cohn ZA (1979) Extracellular cytolysis by activated macrophages and granulocytes. II. Hydrogen peroxide as a mediator of cytotoxicity. J Exp Med 149 : 100 113.
112. Nimrichter L, Barreto-Bergter E, Mendonca-Filho RR, Kneipp LF, Mazzi MT, Salve P, Farias SE, Wait R, Alviano CS Rodrigues ML (2004) A monoclonal antibody to glucosylceramide inhibits the growth of Fonsecaea pedrosoi and enhances the antifungal action of mouse macrophages. Microb Infect 6 : 657 665.
113. Nimrichter L, Cerqueira MD, Leitão EA, Miranda K, Nakayasu ES, Almeida SR, Almeida IC, Alviano CS, Barreto-Bergter E Rodrigues ML (2005) Structure, cellular distribution, antigenicity, and biological functions of Fonsecaea pedrosoi ceramide monohexosides. Infect Immun 73 : 7860 7868.
114. Nobrega JP, Rosemberg S, Adami AM, Heins-Vaccari EM, Lacaz CS De Brito T (2003) Fonsecaea pedrosoi cerebral phaeohyphomycosis (" chromoblastomycosis"): first human culture-proven case reported in Brazil. Rev Inst Med Trop São Paulo 45 : 217 220.
115. Nosanchuk JD Casadevall A (2003) The contribution of melanin to microbial pathogenesis. Cell Microbiol 5 : 203 223.
116. Nosanchuk JD Casadevall A (2006) Impact of melanin on microbial virulence and clinical resistance to antimicrobial compounds. Antimicrob Agents Chemother 50 : 3519 3528.
117. Nosanchuk JD, Rosas AL Casadevall A (1998) The antibody response to fungal melanin in mice. J Immunol 160 : 6026 6031.
118. Nosanchuk JD, Gomez BL Youngchim S (2002) Histoplasma capsulatum synthesizes melanin-like pigments in vitro and during mammalian infection. Infect Immun 70 : 5124 5131.
119. Nosanchuk JD, van Duin D, Mandal P, Aisen P, Legendre AM Casadevall A (2004) Blastomyces dermatitidis produces melanin in vitro and during infection. FEMS Microbiol Lett 239 : 187 193.
120. Oda LM, Kubelka CF, Alviano CS Travassos LR (1983) Ingestion of yeast forms of Sporothrix schenckii by mouse peritoneal macrophages. Infect Immun 39 : 497 504.
121. Osherov N May GS (2001) The molecular mechanisms of conidial germination. FEMS Microbiol Lett 199 : 153 160.
122. Palella FJ Jr., Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ Holmberg SD (1998) Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient study investigation. N Engl J Med 338 : 853 860.
123. Palmeira VF (2006) Peptidases secretadas por conídios de Fonsecaea pedrosoi: efeito de inibidores proteolíticos no crescimento, ultraestrutura e interação com hospedeiro. PhD Thesis, Instituto de Microbiologia Prof. Paulo de Góes (IMPPG), Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brasil.
124. Palmeira VF, Kneipp LF, Alviano CS Santos ALS (2006a) Secretory aspartyl peptidase from mycelia of Fonsecaea pedrosoi: effect of HIV peptidase inhibitors. Res Microbiol 157 : 819 826.
125. Palmeira VF, Kneipp LF, Alviano CS Santos ALS (2006b) The major chromoblastomycosis fungal pathogen Fonsecaea pedrosoi extracellularly releases proteolytic enzymes whose expression is modulated by culture medium composition: implications on the fungal development and cleavage of key's host structures. FEMS Immunol Med Microbiol 46 : 21 29.
126. Perez-Blanco M, Hernandez Valles R, Garcia-Humbria L Yegres F (2006) Chromoblastomycosis in children and adolescents in the endemic area of the Falcon State, Venezuela. Med Mycol 44 : 467 471.
127. Pinto MR, Rodrigues ML, Travassos LR, Haido RM, Wait R Barreto-Bergter E (2002) Characterization of glucosylceramides in Pseudallescheria boydii and their involvement in fungal differentiation. Glycobiology 12 : 251 260.
128. Poirriez J, Breuillard F, Francois N, Fruit J, Sendid B, Gross S Dei-Cas E (2000) A case of chromomycosis treated by a combination of cryotherapy, shaving, oral 5-fluorocytosine, and oral amphotericin B. Am J Trop Med Hyg 63 : 61 63.
129. Pozio E Morales MA (2005) The impact of HIV-protease inhibitors on opportunistic parasites. Trends Parasitol 21 : 58 63.
130. Quevedo WC, Fitzpatrick TB, Szabo G Jimbow K (1987) Biology of melanocytes. Dermatology in General Medicine (Fitzpatrick TB, ed), pp. 224 251. McGraw-Hill, New York.
131. Rao MB, Tanksale AM, Ghatge MS Deshpande VV (1998) Molecular and biotechnological aspects of microbial proteases. Microbiol Mol Biol Rev 62 : 597 635.
132. Raposo G Marks MS (2002) The dark side of lysosome-related organelles: specialization of the endocytic pathway for melanosome biogenesis. Traffic 3 : 237 248.
133. Rast DM, Baumgartner D, Mayer C Hollenstein GO (2003) Cell wall-associated enzymes in fungi. Phytochemistry 64 : 339 366.
134. Reiss E Nikerson WJ (1974) Control of dimorphism in Phialophora verrucosa. Sabouraudia 12 : 202 213.
135. Rhodes JC, Polacheck I Kwon-Chung KJ (1982) Phenoloxidase activity and virulence in isogenic strains of Cryptococcus neoformans. Infect Immun 36 : 1175 1184.
136. Richard-Blum S, Hartmann DJ Esterre P (1998) Monitoring of extracellular matrix metabolism and cross-linking in tissue, serum and urine of patients with chromoblastomycosis, a chronic skin fibrosis. Eur J Clin Invest 28 : 748 754.
137. Rippon JW (1988) Chromoblastomycosis. Medical Mycology (Sauders WB, ed), pp. 276 296. Harcourt Brace Jovanovich Inc., Philadelphia.
138. Rittershaus PC, Kechichian TB, Allegood JC, Merrill AH Jr., Hennig M, Luberto C Del Poeta M (2006) Glucosylceramide synthase is an essential regulator of pathogenicity of Cryptococcus neoformans. J Clin Invest 116 : 1651 1659.
139. Rodrigues CO, Dutra PML, Souto-Padrón T, Cordeiro RSB Lopes AHCS (1996) Effect of platelet-activating factor on cell differentiation of Trypanosoma cruzi. Biochem Biophys Res Commun 223 : 735 740.
140. Rodrigues ML, Rozental S, Coceiro JNSS, Angluster J, Alviano CS Travassos LR (1997) Identification of N-acetylneuraminic acid and its 9-O-acetylated derivative on the cell surface of Cryptococcus neoformans: influence on fungal phagocytosis. Infect Immun 65 : 4937 4942.
141. Rodrigues ML, Travassos LR, Miranda KR, Franzen AJ, Rozental S, de Souza W, Alviano CS Barreto-Bergter E (2000) Human antibodies against a purified glucosylceramide from Cryptococcus neoformans inhibit cell budding and fungal growth. Infect Immun 68 : 7049 7060.
142. Rodrigues ML, Dos Reis FCG, Puccia R, Travassos LR Alviano CS (2003) Cleavage of human fibronectin and other basement membrane-associated proteins by a Cryptococcus neoformans serine peptidase. Microb Pathogen 34 : 65 71.
143. Rodrigues ML, Nimrichter L, Oliveira DL, Frases S, Miranda K, Zaragoza O, Alvarez M, Nakouzi A, Feldmesser M Casadevall A (2007) Vesicular polysaccharide export in Cryptococcus neoformans is a eukaryotic solution to the problem of fungal trans-cell wall transport. Eukaryot Cell 6 : 48 59.
144. Roggentin P, Krug G, Schauer R Brasch J (1999) Lack of sialidase activity in Candida albicans and Candida glabrata. Mycoses 42 : 33 36.
145. Romero-Martinez R, Wheeler M, Guerrero-Plata A, Rico G Torres-Guerrero H (2000) Biosynthesis and functions of melanin in Sporothrix schenckii. Infect Immun 68 : 3696 3703.
146. Rosas AL, Nosanchuk JD, Feldmesser M, Cox GM, McDade HC Casadevall A (2000) Synthesis of polymerized melanin by Cryptococcus neoformans in infected rodents. Infect Immun 68 : 2845 2853.
147. Rosas AL, Nosanchuk JD Casadevall A (2001) Passive immunization with melanin-binding monoclonal antibodies prolongs survival of mice with lethal Cryptococcus neoformans infection. Infect Immun 69 : 3410 3412.
148. Rosen T Overholt M (1996) Persistent viability of the medlar body. Int J Dermatol 35 : 96 98.
149. Royal GC Jr., Nandedkar AK, Sampson CC Faggett T (1984) Neuraminidase production by Candida albicans. J Natl Med Assoc 76 : 143 145.
150. Rozental S, Alviano CS De Souza W (1994) The in vitro susceptibility of Fonsecaea pedrosoi to activated macrophages. Mycopathologia 126 : 85 91.
151. Rozental S, Alviano CS De Souza W (1996) Fine structure and cytochemical study of the interaction between Fonsecaea pedrosoi and rat polymorphonuclear leukocyte. J Med Vet Mycol 34 : 323 330.
152. Saberi H, Kashfi A, Hamidi S, Tabatabai SA Mansouri P (2003) Cerebral phaeohyphomycosis masquerading as a parafalcian mass: case report. Surg Neurol 60 : 354 359.
153. Salgado CG, Silva JP, Diniz JAP, Silva MB, Costa PF, Teixeira C Salgado UI (2004) Isolation of Fonsecaea pedrosoi from thorns of Mimosa pudica, a probable natural source of chromoblastomycosis. Rev Inst Med Trop Sao Paulo 46 : 33 36.
154. Salgado CG, Silva JP, Silva MB, Costa PF Salgado UI (2005) Cutaneous diffuse chromoblastomycosis. Lancet Infect Dis 5 : 528.
155. Santos ALS Soares RMA (2005) Candida guilliermondii isolated from HIV-infected human secretes a 50 kDa serine peptidase that cleaves a broad spectrum of proteinaceous substrates. FEMS Immunol Med Microbiol 43 : 13 20.
156. Santos ALS, Carvalho IM, Silva BA, Portela MB, Alviano CS Soares RMA (2006) Secretion of serine peptidase by a clinical strain of Candida albicans: influence of growth conditions and cleavage of human serum proteins and extracellular matrix components. FEMS Immunol Med Microbiol 46 : 209 220.
157. Santosh V, Khanna N, Shankar SK, Pal L, Das S, Chandramukhi A Kolluri VR (1995) Primary mycotic abscess of the brain caused by Fonsecaea pedrosoi. Case report. J Neurosurg 82 : 128 130.
158. Schauer R (1982) Chemistry, metabolism and biological functions of sialic acids. Adv Carbohydr Chem Biochem 40 : 131 234.
159. Schauer R Kamerling JP (1997) Chemistry, biochemistry and biology of sialic acids. Glycoproteins, II (Montreuil J, Vliegenthart JFG Schachter H, eds), pp. 243 402. Elsevier, Amsterdam.
160. Seiji M, Shimao K, Birbeck MSC Fitspatrick TB (1963) Subcellular localization of melanin biosynthesis. Ann NY Acad Sci 100 : 497 533.
161. Sepkowitz KA (1998) Effect of HAART on natural history of AIDS-related opportunistic disorders. Lancet 351 : 228 230.
162. Silva CL Ekizlerian S (1985) Granulomatous reactions induced by lipids extracted from Fonsecaea pedrosoi, F. compactum, Cladosporium carrionii and Phialophora verrucosum. J General Microbiol 131 : 187 194.
163. Silva JP, De Souza W Rozental S (1999) Chromoblastomycosis: a retrospective study of 325 cases on Amazonic region (Brazil). Mycophatologia 143 : 171 175.
164. Silva JP, Alviano DS, Alviano CS, De Souza W, Travassos LR, Diniz JAP Rozental S (2002) Comparison of Fonsecaea pedrosoi sclerotic cells obtained in vivo and in vitro: ultrastructure and antigenicity. FEMS Immunol Med Microbiol 33 : 63 69.
165. Silva MR, Fernandes OF, Costa CR, Chaul A, Morgado LF, Fleury-Junior LF Costa MB (2005) Subcutaneous phaeohyphomycosis by Exophiala jeanselmei in a cardiac transplant recipient. Rev Inst Med Trop Sao Paulo 47 : 55 57.
166. Silva BA, Pinto MR, Soares RMA, Barreto-Bergter E Santos ALS (2006a) Pseudallescheria boydii releases metallopeptidases capable to cleave several proteinaceous compounds. Res Microbiol 157 : 425 432.
167. Silva BA, Santos ALS, Barreto-Bergter E Pinto MR (2006b) Extracellular peptidase in the fungal pathogen Pseudallescheria boydii. Curr Microbiol 53 : 18 22.
168. Silva JP, Silva MB, Salgado UI, Diniz JA, Rozental S Salgado CG (2007) Phagocytosis of Fonsecaea pedrosoi conidia, but not sclerotic cells caused by Langerhans cells, inhibits CD40 and B7-2 expression. FEMS Immunol Med Microbiol 50 : 104 111.
169. Singh N (2000) Infections in solid organ transplant recipients. Curr Opin Infect Dis 13 : 343 347.
170. Sotto MN, De Brito T, Silva AMG, Vidal M Martins Castro LG (2004) Antigen distribution and antigen-presenting cells in skin biopsies of human chromoblastomycosis. J Cutan Pathol 31 : 14 18.
171. Souza ET, Silva-Filho FC, De Souza W, Alviano CS, Angluster J Travassos LR (1986) Identification of sialic acids on the cell surface of hyphae and conidia of the human pathogen Fonsecaea pedrosoi. J Med Vet Mycol 24 : 145 153.
172. Stahl PD, Rodman JS, Miller MJ Schlesinger PH (1978) Evidence for receptor-mediated binding of glycoproteins, glycoconjugates and lysosomal glycosidases by alveolar macrophages. Proc Natl Acad Sci USA 75 : 1399 1403.
173. Stanley P (1984) Glycosylation mutants of animal cells. Annu Rev Genet 18 : 525 552.
174. Stanley P (1985) Membrane mutants of animal cells: rapid identification of those with primary defect in glycosylation. Mol Cell Biol 5 : 923 929.
175. Szaniszlo PJ, Hsieh PH Marlowe JD (1976) Induction and ultrastructure of the multicellular (sclerotic) morphology in Phialophora dermatitidis. Mycologia 68 : 117 130.
176. Szaniszlo PJ, Jacobs CW Geis PA (1983) Dimorphism: morphological and biochemical aspects. Fungi Pathogenic for Humans and Animals. Part A. Biology (Howard DH, ed), pp. 323 426. Marcel Dekker, New York.
177. Tanabe H, Kawasaki M, Mochizuki T Ishizaki H (2004) Species identification and strain typing of Fonsecaea pedrosoi using ribosomal RNA gene internal transcribed spacer regions. Jpn J Med Mycol 45 : 105 112.
178. Teixeira de Sousa MG, Ghosn EEB Almeida SR (2006) Absence of CD4+T Cells impairs host defence of mice infected with Fonsecaea pedrosoi. Scand J Immunol 64 : 595 600.
179. Thevissen K, Warnecke DC, Francois IE, Leipelt M, Heinz E, Ott C, Zahringer U, Thomma BP, Ferket KK Cammue BP (2004) Defensins from insects and plants interact with fungal glucosylceramides. J Biol Chem 279 : 3900 3905.
180. Thevissen K, Francois IE, Aerts AM Cammue BP (2005) Fungal sphingolipids as targets for the development of selective antifungal therapeutics. Curr Drug Targets 6 : 923 928.
181. Tietze C, Schlesinger P Stahl P (1980) Cloroquine and ammonium ion inhibits receptor-mediated endocytosis of mannose-glycoconjugates by macrophages: apparent inhibition of receptor recycling. Biochem Biophys Res Commun 93 : 1 8.
182. Toledo MS, Levery SB, Suzuki E, Straus AH Takahashi HK (2001) Characterization of cerebrosides from the thermally dimorphic mycopathogen Histoplasma capsulatum: expression of 2-hydroxy fatty N-acyl (E)-Delta(3)-unsaturation correlates with the yeast-mycelium phase transition. Glycobiology 11 : 113 124.
183. Tomson N, Abdullah A Maheshwari MB (2006) Chromomycosis caused by Exophiala spinifera. Clin Exp Dermatol 31 : 239 241.
184. Tsai HF, Fujii I Watanabe A (2001) Pentaketide melanin biosynthesis in Aspergillus fumigatus requires chain-length shortening of a heptaketide precursor. J Biol Chem 276 : 29292 29298.
185. Tsuneto LT, Arce-Gomez B, Petzl-Erler ML Queiroz-Telles F (1989) HLA-A29 and genetic susceptibility to chromoblastomycosis. J Med Vet Mycol 27 : 181 185.
186. Uchida Y, Tsukada Y Sugimori T (1974) Production of microbial neuraminidases induced by colominic acid. Biochim Biophys Acta 350 : 425 431.
187. Uribe F, Zuluaga AI, Leon W Restrepo A (1989) Histopathology of chromoblastomycosis. Mycopathologia 105 : 1 6.
188. van Burik JAH Magee PT (2001) Aspects of fungal pathogenesis in humans. Annu Rev Microbiol 55 : 743 772.
189. Verstrepen KJ Klis FM (2006) Flocculation, adhesion and biofilm formation in yeasts. Mol Microbiol 60 : 5 15.
190. Wallukat G (2002) The beta-adrenergic receptors. Herz 27 : 683 690.
191. Wasylnka JA, Simmer MI Moore MM (2001) Differences in sialic acid density in pathogenic and non-pathogenic Aspergillus species. Microbiology 147 : 869 877.
192. Ziganshin AU, Ziganshina LE, King BF Burnstock G (1995) Characteristics of ecto-ATPase of Xenopus oocytes and the inhibitory actions of suramin on ATP breakdown. Pflügers Arch 429 : 412 418.